Publikation
First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors
Wissenschaftlicher Artikel/Review - 10.12.2020
Baird Richard D, Fischer Stefanie, Azaro Analia, Harstrick Andreas, Stumpp Michael T, Leupin Nicolas, Dawson Keith M, Fiedler Ulrike, Zitt Christof, Rodón Jordi, Harris Adrian, Lord Simon, Middleton Mark, Linossi Constanza, Omlin Aurelius
Baird, Richard D
Linossi, Constanza
Middleton, Mark
Lord, Simon
Harris, Adrian
Rodón, Jordi
Zitt, Christof
Fiedler, Ulrike
Dawson, Keith M
Leupin, Nicolas
Stumpp, Michael T
Harstrick, Andreas
Azaro, Analia
Fischer, Stefanie
Oberärztin mbFMedizinische Onkologie und Hämatologie · Dept. I